NSE: ACUTAAS | BSE: 543349

Expensive Star

Download real time

2083.80 -103.90 (-4.75%)

113.38% Gain from 52W Low

412.2K NSE+BSE Volume

NSE 13 Mar, 2026 3:31 PM (IST)

17,060.3

Market Cap

High in industry

Beta 1Year

Very High Volatility

Acutaas Chemicals Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ACUTAAS, BSE:543349 Acutaas Chemicals Ltd.

Search Inside the pdf :

Acutaas Chemicals Ltd.

29 Jan 2026

2083.80

-4.75%

ACUTAAS CHEMICALS LIMITED

Buy: Acutaas Chemicals Ltd.

Geojit BNP Paribas

Acutaas Chemicals Ltd (formerly Ami Organics), incorporated in 2004, is a leading advanced pharmaceutical intermediates manufacturer (85% FY25 revenue) and specialty chemicals (15%) with a strong presence across CDMO, advanced intermediates and emerging specialty chemistry platforms such as battery chemicals and semiconductor chemicals. The company supports over...

Acutaas Chemicals Ltd. is trading below its 30 day SMA of 2093.0

Acutaas Chemicals Ltd.

29 Jan 2026

2083.80

-4.75%

Acutaas Chemicals: Q3FY26 Result Review

Buy: Acutaas Chemicals Ltd.

Target

IDBI Capital

Acutaas Chemicals registered a superlative performance in Q3FY26. Revenue, EBITDA and PAT registered strong growth of 43%,119% and 140% respectively on YoY terms. We believe the company can clock in PAT CAGR of 54% from FY25-FY28E riding strongly on several growth levers led by the CDMO business. Robust growth in the Fermion contract coupled with healthy growth in the NonCDMO Business augur strongly for profitability prospects. We believe that strong traction in key molecules will continue along with further scale up of CDMO business with the increasing ramp up of the Ankleshwar unit. We have revised estimates upwards to factor in stronger margin profile. We roll forward...

Acutaas Chemicals has gained 44.50% in the last 6 Months

Acutaas Chemicals Ltd.

14 Nov 2025, 12:00AM

2083.80

-4.75%

At the Apex of Chemistry

Buy: Acutaas Chemicals Ltd.

FundsIndia

Strategic Expansion: Battery & semiconductor chemical segments

Number of FII/FPI investors increased from 179 to 199 in Dec 2025 qtr.

Acutaas Chemicals Ltd.

27 Oct 2025

2083.80

-4.75%

Strong quarter with robust growth and margin expansion.

Accumulate: Acutaas Chemicals Ltd.

Recommendation Target

Deven Choksey

Acutas Chemicals delivered robust revenue and profit growth, driven by strong performance in API and specialty chemicals segment.

Acutaas Chemicals Ltd. is trading above its 200 day SMA of 1559.8

Acutaas Chemicals Ltd.

23 Oct 2025

2083.80

-4.75%

Acutaas Chemicals: Q2FY26 Result Review

Buy: Acutaas Chemicals Ltd.

Target

IDBI Capital

Acutaas Chemicals registered a superlative performance in Q2FY26. Revenue, EBITDA and PAT registered strong growth of 24%,95% and 94% respectively on YoY terms. We believe the company will can clock in revenue CAGR of 25-30% for the next 2 years with margins upwards of 29%. The growth will be propelled by strong growth in the advanced pharma intermediates business owing to strong traction in CDMO business and targeting of more molecules which will go off patent. We believe that strong traction in key molecules will continue along with further scale up of CDMO business with the increasing ramp up of the...

Acutaas Chemicals Ltd. is trading above its 200 day SMA of 1559.8

Acutaas Chemicals Ltd.

31 Jul 2025

2083.80

-4.75%

Acutaas Chemicals: Q1FY26 Result Review

Buy: Acutaas Chemicals Ltd.

Target

IDBI Capital

Acutaas Chemicals registered a strong performance in Q1FY26. Revenue, EBITDA and PAT registered strong growth of 17%,73% and 218% respectively on YoY terms albeit from a weak base. We believe the company will can clock in revenue CAGR of 25-30% for the next 2 years with margins upwards of 23%. The growth will be propelled by strong growth in the advanced pharma intermediates business owing to strong traction in CDMO business and targeting of more molecules which will go off patent. We believe that strong traction in key molecules will continue along with further scale up of CDMO business with...

Acutaas Chemicals Ltd. has an average target of 2173.50 from 4 brokers.

Acutaas Chemicals Ltd.

24 Jul 2025

2083.80

-4.75%

Stock Flash

Buy: Acutaas Chemicals Ltd.

Deven Choksey

Acutaas Chemicals Limited (formerly known as Ami Organics Limited) has announced a strategic investment of up to INR 2 Bn in its wholly owned subsidiary, Acutaas Advance Material Limited (AAML), to support expansion in the semiconductor chemicals business.